Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline

[at noodls] – – Company to Advance Development of Novel Oncology Therapeutics Including IAP Inhibitor GDC-0917 – – Conference Call Today at 8:30 a.m. EST – LEXINGTON, Mass., Nov. 28, 2012 (GLOBE NEWSWIRE) — Curis, … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard